Provided By PR Newswire
Last update: Nov 10, 2025
Mr. Levav's appointment ensures seamless and focused organizational structure as Company expands commercial activities in the U.S. following FDA marketing clearance for ProSense®
Read more at prnewswire.com0.649
-0.05 (-7.23%)
Find more stocks in the Stock Screener


